AR007863A1 - Formula de vacuna para bovinos, su utilizacion e instalacion portatil de vacunacion bovina - Google Patents
Formula de vacuna para bovinos, su utilizacion e instalacion portatil de vacunacion bovinaInfo
- Publication number
- AR007863A1 AR007863A1 ARP970103115A ARP970103115A AR007863A1 AR 007863 A1 AR007863 A1 AR 007863A1 AR P970103115 A ARP970103115 A AR P970103115A AR P970103115 A ARP970103115 A AR P970103115A AR 007863 A1 AR007863 A1 AR 007863A1
- Authority
- AR
- Argentina
- Prior art keywords
- bovine
- portable
- vaccination
- installation
- vaccine formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18541—Use of virus, viral particle or viral elements as a vector
- C12N2760/18543—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La fórmula de vacuna bovina polinucleotídica comprende una cantidad eficaz por vía intradérmica de un plásmido que asocia una secuencia de ADN quecodifica para un inmunógeno de un agente patógeno bovino con un promotor que permite la expresiónde un inmunógeno in vivo en las células de la piel,estando adaptada esta fórmula de vacuna a la administración intradérmica por un aparato de administración por chorro líquido. La instalación portátil devacunación bovina comprende un aparato deadminis tración por chorro líquido y un frasco adaptado que comprende varias dosis de esta fórmula de vacuna,estando disenado el aparato de administración para suministrar una dosis de fórmula de vacuna por vía intradérmica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9609402A FR2751228B1 (fr) | 1996-07-19 | 1996-07-19 | Vaccin polynucleotidique bovin pour voie intradermique |
Publications (1)
Publication Number | Publication Date |
---|---|
AR007863A1 true AR007863A1 (es) | 1999-11-24 |
Family
ID=9494496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970103115A AR007863A1 (es) | 1996-07-19 | 1997-07-11 | Formula de vacuna para bovinos, su utilizacion e instalacion portatil de vacunacion bovina |
Country Status (23)
Country | Link |
---|---|
US (2) | US6451770B1 (es) |
EP (1) | EP0918540B1 (es) |
JP (1) | JP2000515522A (es) |
AP (1) | AP9701045A0 (es) |
AR (1) | AR007863A1 (es) |
AT (1) | ATE224732T1 (es) |
AU (1) | AU722878B2 (es) |
BR (1) | BR9710498A (es) |
CA (1) | CA2261334C (es) |
CO (1) | CO4700344A1 (es) |
CZ (1) | CZ298216B6 (es) |
DE (1) | DE69715879T2 (es) |
ES (1) | ES2184122T3 (es) |
FR (1) | FR2751228B1 (es) |
HU (1) | HU224833B1 (es) |
ID (1) | ID19427A (es) |
IL (1) | IL127914A (es) |
MA (1) | MA24271A1 (es) |
MX (1) | MXPA99000684A (es) |
NZ (1) | NZ333752A (es) |
PL (1) | PL189184B1 (es) |
WO (1) | WO1998003196A1 (es) |
ZA (1) | ZA976285B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7294338B2 (en) * | 1996-07-19 | 2007-11-13 | Merial | Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies |
FR2751228B1 (fr) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2804028B1 (fr) * | 2000-01-21 | 2004-06-04 | Merial Sas | Vaccins adn ameliores pour animaux de rente |
US7078388B2 (en) * | 2000-01-21 | 2006-07-18 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
EP2390352A1 (en) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
US20050214316A1 (en) | 2003-11-13 | 2005-09-29 | Brown Thomas P | Methods of characterizing infectious bursal disease virus |
EP1718770B1 (en) | 2004-02-19 | 2011-05-25 | The Governors of the University of Alberta | Leptin promoter polymorphisms and uses thereof |
CA2570156C (en) * | 2004-06-04 | 2014-09-30 | Merial Limited | Needle-free administration of felv vaccines |
DE602006013117D1 (de) | 2005-04-25 | 2010-05-06 | Merial Ltd | Nipah-virus-impfstoffe |
US8998881B2 (en) | 2005-08-10 | 2015-04-07 | Alza Corporation | Method for delivering drugs to tissue under microjet propulsion |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
EP2186823A1 (en) | 2005-11-14 | 2010-05-19 | Merial Limited | Gene therapy for renal failure |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
EP2147105B1 (en) | 2007-05-02 | 2013-04-24 | Merial Limited | Dna plasmids having improved expression and stability |
US20080274137A1 (en) * | 2007-05-02 | 2008-11-06 | Jean Christophe Francis Audonnet | DNA plasmids having improved expression and stability |
CN102271704A (zh) | 2008-11-28 | 2011-12-07 | 梅里亚有限公司 | 重组禽流感疫苗及其用途 |
CA2757030C (en) | 2009-04-03 | 2019-01-15 | Merial Limited | Vectors comprising newcastle disease viruses and compositions thereof |
JP5933451B2 (ja) | 2009-12-28 | 2016-06-08 | メリアル リミテッド | 組換えndv抗原及びその使用 |
US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
AU2011224188B2 (en) | 2010-03-12 | 2015-01-22 | Boehringer Ingelheim Animal Health USA Inc. | Bluetongue virus recombinant vaccines and uses thereof |
US8986706B2 (en) | 2010-08-31 | 2015-03-24 | Merial, Inc. | Newcastle disease virus vectored herpesvirus vaccines |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
AU2012240246A1 (en) | 2011-04-04 | 2013-05-09 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
EP2694677A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
KR102007444B1 (ko) | 2011-04-25 | 2019-08-06 | 어드밴스드 바이오사이언스 라보라토리즈, 인코포레이티드 | 절단형 hiv 피막 단백질(env), 이와 관련된 방법 및 조성물 |
MX361804B (es) | 2011-05-27 | 2018-12-17 | Boehringer Ingelheim Animal Health Usa Inc | Vacunas genéticas contra el virus hendra y el virus nipah. |
EP2714077B1 (en) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
HUE035774T2 (en) | 2011-08-12 | 2018-05-28 | Merial Inc | Biological substances, in particular vaccines, preserved by vacuum |
WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
HUE033858T2 (en) | 2012-02-14 | 2018-01-29 | Merial Inc | Rotavirus unit vaccines and method for their preparation and use |
MX360415B (es) | 2012-02-14 | 2018-10-31 | Merial Inc | Vectores poxvirales recombinantes que expresan proteinas tanto de rabia como de ox40, y vacunas hechas a partir de los mismos. |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
EP2861248B1 (en) | 2012-06-13 | 2017-11-15 | Merial, Inc. | Reassortant btv and ahsv vaccines |
WO2014164697A1 (en) | 2013-03-12 | 2014-10-09 | Merial Limited | Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof |
CA2966191A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
AU2016282772B2 (en) | 2015-06-23 | 2019-09-05 | Boehringer Ingelheim Animal Health USA Inc. | PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof |
EP3337503A1 (en) | 2015-08-20 | 2018-06-27 | Merial, Inc. | Fcv recombinant vaccines and uses thereof |
MA43016A (fr) | 2015-09-29 | 2018-08-08 | Merial Inc | Vaccins à particules pseudo-virales (vlp) de parvovirus canin (cpv) et utilisations associées |
BR112018010494A8 (pt) | 2015-11-23 | 2019-02-26 | Merial Inc | proteínas de fusão fmdv e e2 e seus usos |
TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2348709A1 (fr) * | 1976-04-23 | 1977-11-18 | Pistor Michel | Procede de traitement mesotherapique et dispositif d'injection,formant micro-injecteur automatique,en comportant application |
FR2652257B1 (fr) * | 1989-09-26 | 1992-11-27 | Rhone Merieux | Installation portative de vaccination porcine. |
JPH05509231A (ja) * | 1990-07-24 | 1993-12-22 | ザ ユーエイビー リサーチ ファンデーション | ウシrsウイルスの組換えdna、タンパク質ワクチン、抗体、および形質転換細胞の使用法 |
GB9118204D0 (en) * | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
US5643578A (en) * | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
DE69426390T2 (de) * | 1993-07-31 | 2001-04-12 | Weston Medical Ltd | Nadelloser injektor |
DE69536091D1 (de) * | 1994-01-27 | 2010-09-09 | Univ Massachusetts Medical | Immunisierung durch Impfung von DNS Transkriptionseinheit |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
FR2751228B1 (fr) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
-
1996
- 1996-07-19 FR FR9609402A patent/FR2751228B1/fr not_active Expired - Fee Related
-
1997
- 1997-07-11 AR ARP970103115A patent/AR007863A1/es active IP Right Grant
- 1997-07-16 AT AT97934575T patent/ATE224732T1/de not_active IP Right Cessation
- 1997-07-16 PL PL97331237A patent/PL189184B1/pl unknown
- 1997-07-16 CZ CZ0010699A patent/CZ298216B6/cs not_active IP Right Cessation
- 1997-07-16 ZA ZA976285A patent/ZA976285B/xx unknown
- 1997-07-16 IL IL12791497A patent/IL127914A/en not_active IP Right Cessation
- 1997-07-16 NZ NZ333752A patent/NZ333752A/en not_active IP Right Cessation
- 1997-07-16 HU HU9902792A patent/HU224833B1/hu unknown
- 1997-07-16 CA CA2261334A patent/CA2261334C/en not_active Expired - Lifetime
- 1997-07-16 AU AU37732/97A patent/AU722878B2/en not_active Expired
- 1997-07-16 DE DE69715879T patent/DE69715879T2/de not_active Expired - Lifetime
- 1997-07-16 BR BR9710498-1A patent/BR9710498A/pt not_active Application Discontinuation
- 1997-07-16 JP JP10506636A patent/JP2000515522A/ja active Pending
- 1997-07-16 WO PCT/FR1997/001322 patent/WO1998003196A1/fr active IP Right Grant
- 1997-07-16 MA MA24718A patent/MA24271A1/fr unknown
- 1997-07-16 EP EP97934575A patent/EP0918540B1/fr not_active Expired - Lifetime
- 1997-07-16 ID IDP972481A patent/ID19427A/id unknown
- 1997-07-16 ES ES97934575T patent/ES2184122T3/es not_active Expired - Lifetime
- 1997-07-16 MX MXPA99000684A patent/MXPA99000684A/es active IP Right Grant
- 1997-07-17 AP APAP/P/1997/001045A patent/AP9701045A0/en unknown
- 1997-07-18 CO CO97040984A patent/CO4700344A1/es unknown
-
1999
- 1999-01-15 US US09/232,469 patent/US6451770B1/en not_active Expired - Lifetime
-
2002
- 2002-02-15 US US10/077,489 patent/US6803361B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
HUP9902792A2 (hu) | 1999-12-28 |
CZ298216B6 (cs) | 2007-07-25 |
CA2261334A1 (en) | 1998-01-29 |
CZ10699A3 (cs) | 1999-04-14 |
ES2184122T3 (es) | 2003-04-01 |
MXPA99000684A (es) | 2006-02-10 |
AU3773297A (en) | 1998-02-10 |
HU224833B1 (en) | 2006-03-28 |
WO1998003196A1 (fr) | 1998-01-29 |
JP2000515522A (ja) | 2000-11-21 |
NZ333752A (en) | 2000-06-23 |
DE69715879T2 (de) | 2003-01-23 |
IL127914A (en) | 2001-05-20 |
HUP9902792A3 (en) | 2000-03-28 |
AU722878B2 (en) | 2000-08-10 |
FR2751228B1 (fr) | 1998-11-20 |
AP9701045A0 (en) | 1997-07-31 |
CA2261334C (en) | 2010-11-16 |
PL189184B1 (pl) | 2005-07-29 |
EP0918540B1 (fr) | 2002-09-25 |
PL331237A1 (en) | 1999-07-05 |
US6451770B1 (en) | 2002-09-17 |
ATE224732T1 (de) | 2002-10-15 |
BR9710498A (pt) | 2000-01-18 |
US6803361B2 (en) | 2004-10-12 |
ID19427A (id) | 1998-07-09 |
US20020137716A1 (en) | 2002-09-26 |
IL127914A0 (en) | 1999-11-30 |
DE69715879D1 (de) | 2002-10-31 |
EP0918540A1 (fr) | 1999-06-02 |
MA24271A1 (fr) | 1998-04-01 |
CO4700344A1 (es) | 1998-12-29 |
FR2751228A1 (fr) | 1998-01-23 |
ZA976285B (en) | 1999-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR007863A1 (es) | Formula de vacuna para bovinos, su utilizacion e instalacion portatil de vacunacion bovina | |
UY39060A (es) | Composiciones y métodos para prevenir y tratar la infección por coronavirus - vacunas sars-cov-2 | |
DK216289A (da) | Rekombinant - dna - afledte bordetella-toxinunderenheder og analoge deraf | |
NO20021431L (no) | Intranasal influensavirus vaksine | |
ES2098029T3 (es) | Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado. | |
BR0209041A (pt) | Emplastro de imunização de disposição de microprojeção e método | |
WO2005016239A3 (en) | Molecules enhancing dermal delivery of influenza vaccines | |
ES2113444T3 (es) | Medicamentos. | |
AR035586A1 (es) | Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn | |
NO900151L (no) | Anordning for kontrollert tilfoersel av et eller flere fordelaktige midler. | |
DE60012711D1 (de) | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe | |
GB0109297D0 (en) | Vaccine | |
ES2183486T3 (es) | Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo. | |
CO4440631A1 (es) | Vacunacion in ovo contra la coccidiosis | |
ES2075325T3 (es) | Subunidad de vacuna contra el actinobacillus pleuropneumoniae. | |
GB9722682D0 (en) | Pharmaceutical products | |
AR011509A1 (es) | Composicion de vacuna que comprende antigenos de difteria, tetano y tos ferina(pertusis) acelular y su uso para la manufactura de un medicamento util como reforzador de vacuna. | |
ES2061647T3 (es) | Vacuna contra el virus de la enfermedad de newcastle y metodo para la aplicacion de la misma. | |
ES2069099T3 (es) | Vacuna recombinante para la pleuroneumonia porcina. | |
ES2172171T3 (es) | Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles. | |
ES2043901T3 (es) | Adyuvante para la terapia inmunologica del cancer. | |
ECSP972184A (es) | Vacuna polinucleotidica destinada a bovinos por via intradermica | |
ES2172558T3 (es) | Lubricante compatible con radiaciones para dispositivos medicos. | |
ES2038064B1 (es) | Instalacion portatil de vacunacion aviar. | |
CA2166718A1 (en) | Vaccine method against swine dysentery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |